| Literature DB >> 23254653 |
Elizabeth G Allan1, Melissa C Kander, Ian Carmichael, Elspeth F Garman.
Abstract
An extensive radiation chemistry literature would suggest that the addition of certain radical scavengers might mitigate the effects of radiation damage during protein crystallography diffraction data collection. However, attempts to demonstrate and quantify such an amelioration and its dose dependence have not yielded consistent results, either at room temperature (RT) or 100 K. Here the information thus far available is summarized and reasons for this lack of quantitative success are identified. Firstly, several different metrics have been used to monitor and quantify the rate of damage, and, as shown here, these can give results which are in conflict regarding scavenger efficacy. In addition, significant variation in results from data collected from crystals treated in nominally the same way has been observed. Secondly, typical crystallization conditions contain substantial concentrations of chemical species which already interact strongly with some of the X-ray-induced radicals that the added scavengers are intended to intercept. These interactions are probed here by the complementary technique of on-line microspectrophotometry carried out on solutions and crystals held both at 100 K and RT, the latter enabled by the use of a beamline-mounted humidifying device. With the help of computational chemistry, attempts are made to assign some of the characteristic spectral features observed experimentally. A further source of uncertainty undoubtedly lies in the challenge of reliably measuring the parameters necessary for the accurate calculation of the absorbed dose (e.g. crystal size and shape, beam profile) and its distribution within the volume of the crystal (an issue addressed in detail in another article in this issue). While microspectrophotometry reveals that the production of various species can be quenched by the addition of scavengers, it is less clear that this observation can be translated into a significant gain in crystal dose tolerance for macromolecular crystallographers.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23254653 PMCID: PMC3526919 DOI: 10.1107/S0909049512046237
Source DB: PubMed Journal: J Synchrotron Radiat ISSN: 0909-0495 Impact factor: 2.616
Mother liquor conditions and results for reported MX scavenger studies where the results from different researchers are inconsistent
Int = introduction: C = co-crystal, S = soak, N/A = not applicable. Damage: G = global damage, Sp = specific damage. Res = response: N = null, P = positive, S = sensitizing, U = unclear. Damage metrics: A### nm = absorbance peak detected by microspectrophotometry at the specified wavelength, |F − F 0| = difference electron density maps calculated from the difference in structure factors for the nth dataset and first dataset. The other metrics are defined in the text.
| Scavenger | Concentration of scavenger | Temperature | System | Int | Conditions | Damage | Metric | Res | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,4-Benzoquinone | 0.4 | 100 K | Disulfide/thiol model solutions | N/A | 0.1 | Sp | A400 nm | P | ||||||||
| 0.5 | RT | Tetragonal HEWL crystals | S | 0.1 | G | Average | P | |||||||||
| Saturated | 100 K | Azurin crystals | S | 5 m | Sp | A632 nm | N | |||||||||
| Saturated | 100 K | Myoglobin crystals | S | 50 m | Sp | A413–A427 nm, A500–A700 nm | N | |||||||||
| 2-Hydroxyethyl methacrylate (HEMA) | 0.01 | RT | Tetragonal HEWL crystals | C | 0.5 | G | Δ | S | ||||||||
| 0.01 | 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| Ascorbate | >0.3 | 100 K | Tetragonal HEWL crystals | C | 0.2 | Sp | A400 nm | P | ||||||||
| 0.5 | 100 K | N9 neuraminidase crystals | S | 1.7 | G | Average | P | |||||||||
| Sp | | | |||||||||||||||
| 0.8 | 92 K | Free SeMet-containing solutions | N/A | 25 m | Sp | XANES | P | |||||||||
| 0.3 | 100 K | Disulfide/thiol model solutions | N/A | 0.1 | Sp | A400 nm | P | |||||||||
| 0.5 | RT | Tetragonal HEWL crystals | C | 0.1 | G | Average | P | |||||||||
| Sp | | | P | ||||||||||||||
| 0.2 | 100 K | Azurin crystals | S | 5 m | Sp | A632 nm | P | |||||||||
| Sp | | | P | ||||||||||||||
| G | Average | P | ||||||||||||||
| 0.2 | 100 K | Myoglobin crystals | S | 50 m | Sp | A413–A427 nm, A500–A700 nm | N | |||||||||
| 1.0 | 100 K | Tetragonal HEWL crystals | C | 0.1 | Sp | | | P | |||||||||
| G | Average | P | ||||||||||||||
| 0.1 | RT, 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| Cysteine | 0.2 | 100 K | Azurin crystals | S | 5 m | Sp | A632 nm | N | ||||||||
| | | N | |||||||||||||||
| 0.2 | 100 K | Myoglobin crystals | S | 50 m | Sp | A413–A427 nm, A500–A700 nm | N | |||||||||
| 0.1 | RT | Tetragonal HEWL crystals | C | 0.5 | G | Δ | S | |||||||||
| 0.1 | 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| DTNB | 0.2 | 100 K | Tetragonal HEWL crystals | S | 25 m | Sp | | | U | ||||||||
| G |
| P | ||||||||||||||
| 0.2 | 100 K | PPE crystals | S | 50 m | Sp | | | P | |||||||||
| G |
| P | ||||||||||||||
| 0.2 | 100 K | Thaumatin crystals | S | 50 m | Sp | | | P | |||||||||
| G |
| P | ||||||||||||||
| Glutathione (oxidized) | 0.2 | 100 K | Tetragonal HEWL crystals | S | 25 m | G |
| N | ||||||||
| 0.2 | 100 K | PPE crystals | S | 50 m | Sp | | | N | |||||||||
| G |
| S | ||||||||||||||
| 0.2 | 100 K | Thaumatin crystals | S | 50 m | Sp | | | P | |||||||||
| G |
| |||||||||||||||
| HEPES | 0.5 | 100 K | Disulfide/thiol model solutions | N/A | 0.1 | Sp | A400 nm | N | ||||||||
| 0.2 | 100 K | Azurin crystals | S | 5 m | Sp | A632 nm | U | |||||||||
| | | U | |||||||||||||||
| Hydroquinone | 0.1 | RT | Tetragonal HEWL crystals | C | 0.5 | G | Δ | S | ||||||||
| 0.1 | 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| Nicotinic acid | 0.2 | 100 K | Tetragonal HEWL crystals | S | 25 m | Sp | | | U | ||||||||
| G |
| P | ||||||||||||||
| 0.2 | 100 K | PPE crystals | S | 50 m | Sp | | | U | |||||||||
| G |
| P | ||||||||||||||
| 0.2 | 100 K | Thaumatin crystals | S | 50 m | Sp | | | P | |||||||||
| G |
| P | ||||||||||||||
| 0.15 | 100 K | Bovine pancreatic trypsin crystals | S | 2.5 mg ml−1 benzamidine, 15 m | G |
| N | |||||||||
|
| 0.16 | RT | Tetragonal HEWL crystals | C | 0.5 | G | Δ | S | ||||||||
| 0.16 | 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| PEG 4000 | 15% | 100 K | Canavalin crystals | S | 0.7% NaCl | G | Average | P | ||||||||
| 20% | 100 K | Fructose 1,6 diphosphatase | S | – | G | Average | P | |||||||||
| 12%, 45% | 100 K | Disulfide/thiol model solutions | N/A | 0.1 | Sp | A400 nm | N | |||||||||
| 0.1 | RT | Tetragonal HEWL crystals | C | 0.5 | G | Δ | S | |||||||||
| 0.1 | 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| Reduced DTT | 0.5 | 100 K | Disulfide/thiol model solutions | N/A | 0.1 | Sp | A400 nm | U | ||||||||
| Sodium nitrate | 0.02 | 195 K |
| N/A | 0.01 | Sp | Mass of native polypeptide | U | ||||||||
| 0.02 | RT | β-Galactosidase solutions | N/A | 0.01 | Sp | Mass of native polypeptide | N | |||||||||
| 1 | 92 K | Free SeMet-containing solutions | N/A | 25 m | Sp | XANES | P | |||||||||
| 1% | 40 K | Tetragonal HEWL crystals | C | 50 m | Sp | | | P | |||||||||
| 0.5 | 100 K | Tetragonal HEWL crystals | S | 0.1 | Sp | A400 nm | P | |||||||||
| Sp | | | P | ||||||||||||||
| G |
| P | ||||||||||||||
| 0.1 | RT | Tetragonal HEWL crystals | S | 0.5 | G | Δ | P | |||||||||
| 0.1 | 100 K | Tetragonal HEWL crystals | S | 0.5 | G | Δ | N | |||||||||
| Styrene | 0.002 | RT | DOB immunoglobulin crystals | C | 70% 0.1 | G |
| P | ||||||||
| Saturated | 100 K | Tetragonal HEWL crystals | C | 25 m | Sp | | | N | |||||||||
| G | Average | N | ||||||||||||||
| 0.1 | RT | Tetragonal HEWL crystals | C | 0.5 | G | Δ | S | |||||||||
| 0.1 | 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| Thiourea | 0.5 | 100 K | Disulfide/thiol model solutions | N/A | 0.1 | Sp | A400 nm | U | ||||||||
| 0.2 | 100 K | Azurin crystals | S | 5 m | G | A632 nm | U | |||||||||
| 0.4 | RT, 100 K | Tetragonal HEWL crystals | C | 0.5 | G | Δ | N | |||||||||
| Trehalose | 1 | 100K | Disulfide/thiol model solutions | N/A | 0.1 | Sp | A400 nm | N | ||||||||
| Tris | 0.02 | RT | β-Galactosidase solutions | N/A | 0.01 | Sp | Mass of native polypeptide | P | ||||||||
| 0.02 | 195 K | β-Galactosidase solutions | N/A | 0.01 | Sp | Mass of native polypeptide | N | |||||||||
| 0.02 | RT | β-Galactosidase lyophilisized powders | N/A | 0.01 | Sp | Mass of native polypeptide | P | |||||||||
| 0.02 | 195 K | β-Galactosidase lyophilisized powders | N/A | 0.01 | Sp | Mass of native polypeptide | N | |||||||||
Southworth-Davies & Garman (2007 ▶). Barker et al. (2009 ▶). Macedo et al. (2009 ▶). Kmetko et al. (2011 ▶). Murray & Garman (2002 ▶). Betts (2003 ▶). Holton (2007 ▶). De la Mora et al. (2011 ▶). Kauffmann et al. (2006 ▶). Nowak et al. (2009 ▶). Cascio et al. (1984 ▶). Audette-Stuart et al. (2005 ▶). Borek et al. (2007 ▶). Zaloga & Sarma (1974 ▶). Sarma & Zaloga (1975 ▶).
Crystals from which data were previously collected at 100 K (De la Mora et al., 2011 ▶)
For data collection statistics see Table 2 of De la Mora et al. (2011 ▶).
| Sample name | Crystal | Soaked/co-crystallized with scavenger | Scavenger (number of datasets) |
|---|---|---|---|
| Native HEWL | HEWL | N/A | None (6) |
| HEWL–ascorbate co-crystal | HEWL | Co-crystallized | Ascorbate (6) |
| HEWL + Nitrate I | HEWL | Soaked for 4 min | Sodium nitrate (final concentration 0.5 |
| HEWL + Nitrate II | HEWL | Soaked for 4 min | Sodium nitrate (final concentration 0.5 |
| HEWL + Nitrate8 | HEWL | Soaked for 8 min | Sodium nitrate (final concentration 0.5 |
Figure 1Results of a reanalysis of the data reported by De la Mora et al. (2011 ▶). (a) B rel for whole data sets and (b) for 5° wedges, and (c) the I/I 0 analysis.
Figure 2On-line microspectrophotometric analysis of HEWL crystallization buffer and its components at RT. (a) A difference absorption spectrum (spectra after irradiation − spectra before irradiation) of the HEWL buffer constituents in water (purple: 1.4 M NaCl at 4.25 MGy; green: 0.1 M NaAc at 2.59 MGy; blue: both at 4.26 MGy). (b) A stacked absorbance spectrum of 30% glycerol upon irradiation, to a final dose of 0.27 MGy as indicated by the red plot. (c) A stacked absorbance spectrum of 30% glycerol and 0.1 M sodium acetate pH 4.8, upon irradiation, to a final dose of 0.3 MGy as indicated by the red plot. (d) A stacked absorbance spectrum of 30% glycerol and 1.4 M sodium chloride upon irradiation, to a final dose of 0.14 MGy as indicated by the red plot. (e) A stacked absorbance spectrum of the crystallization buffer (30% glycerol, 0.1 M sodium acetate pH 4.8, 1.4 M sodium chloride) upon irradiation, to a final dose of 0.39 as indicated by the red plot.
Figure 3A stacked absorption spectrum of 0.5 M sodium nitrate in HEWL cryobuffer (crystallization buffer with water replaced by 30% glycerol) upon irradiation, to a final dose of 0.40 MGy as indicated by the red plot.
Figure 4Changes in absorbance at (a) 400 nm, (b) 580 nm occurring upon irradiation of 35 mg ml−1 HEWL solutions, with and without 0.5 M sodium nitrate at RT. Samples irradiated to a final dose of 1 MGy.
Figure 5Changes in absorbance at 100 K occurring upon irradiation of 35 mg ml−1 HEWL solutions in cryobuffer, with (c and d) and without (a and b) 0.5 M lithium nitrate. (a and c) Absorption spectra at a dose of 0 MGy (blue) and 0.078 MGy (purple). (b and d) Changes in normalized absorbance with time at certain wavelengths of interest. A 1 s X-ray exposure gave an absorbed dose of 0.02 MGy.
Figure 6Three-dimensional absorbance spectrum viewed at 45° of a native HEWL crystal irradiated at 100 K to a final dose of 0.26 MGy (red line).
Figure 7Changes in absorbance at 100 K occurring upon irradiation of a cubic insulin crystal, soaked (c and d) and not soaked (a and b) in 0.375 M lithium nitrate. (a and c) Absorption spectra at a dose of 0 MGy (blue) and 2.73 MGy (purple). (b and d) Changes in normalized absorbance with time at certain wavelengths of interest. 1 s of X-ray exposure is equivalent to a dose of 0.18 MGy.
The values of D 1/2 and ΔB rel/ΔD (slope of D versus B rel graph) resulting from the reanalysis described in the text.
| Metric | Δ |
| |
|---|---|---|---|
| Data used for metric |
|
|
|
| Native HEWL | 1.04 | 0.98 | 12.6 |
| HEWL + Nitrate I | 0.68 | 0.83 | 18.8 |
| HEWL + Nitrate II | 0.41 | 0.46 | 21.2 |
| Mean of HEWL + Nitrate I and II | 0.55 | 0.65 | 20.0 |
| HEWL + Nitrate8 | 0.52 | 0.55 | 10.4 |
| HEWL-ascorbate co-crystal | 0.39 | 0.53 | 24.0 |
The enhancement factors, E and E , obtained using the two different metrics.†
| Enhancement factor (a.u.) |
|
|
|
|---|---|---|---|
| Metric used in reanalysis |
|
|
|
| HEWL + Nitrate I | 1.53 | 1.18 | 1.44 |
| HEWL + Nitrate II | 2.54 | 2.13 | 1.68 |
| Mean Nitrate I and II | 1.90 | 1.52 | 1.59 |
| HEWL + Nitrate8 | 2.01 | 1.77 | 0.83 |
| HEWL–ascorbate co-crystal | 2.65 | 1.86 | 1.90 |
For I/I 0, this is defined as the ratio of D 1/2 (dose to half intensity) with scavenger added to D 1/2 of the native. For the B rel analysis, the enhancement factor is the ratio of ΔB rel/ΔD without scavenger to ΔB rel/ΔD with scavenger (thus a value >1 implies some protection).
| No. of entries | Average concentration (% | Rate ( | |
|---|---|---|---|
| Organic precipitants (2503 samples) | |||
| PEG 4K | 710 | 21.1 | ∼3 × 109 |
| PEG 8K | 488 | 18.1 | " |
| PEG 3.5K | 296 | 20.5 | " |
| PEG 6K | 212 | 16.8 | " |
| MPD | 193 | 38.6 | ∼6 × 108 |
| PEG 400 | 142 | 25.7 | ∼3 × 109 |
| PEG-MME 2000 | 65 | 22.7 | " |
| PEG-MME 5000 | 63 | 20.0 | " |
| PEG 1000 | 57 | 19.8 | " |
| 2-Propanol | 48 | 18.0 | 2.0 × 109 |
| PEG 2000 | 45 | 22.3 | ∼3 × 109 |
| Ethylene glycol | 43 | 20.5 | 2.4 × 109 |
| Ethanol | 43 | 28.8 | 2.0 × 109 |
| PEG 10K | 32 | 22.0 | ∼3 × 109 |
| No. of entries | Average concentration ( | Rate ( | |
|---|---|---|---|
| Salt precipitant (1436 samples) | |||
| Ammonium sulfate | 900 | 1.9 | * |
| Sodium chloride | 124 | 1.7 | 3.0 × 109 |
| Sodium citrate | 76 | 1.1 | 1.5 × 108 |
| Sodium/potassium phosphate | 66 | 1.8 | * |
| Lithium sulfate | 63 | 1.4 | * |
| Sodium formate | 59 | 3.4 | 3.2 × 109 |
| Magnesium sulfate | 29 | 1.7 | * |
| Ammonium phosphate | 29 | 1.5 | * |
| Potassium phosphate | 25 | 2.0 | * |
| Sodium acetate | 21 | 1.2 | 1.0 × 108 |
| Sodium/potassium tartrate | 13 | 1.0 | 1.4 × 109 |
| Caesium chloride | 11 | 2.7 | 3.0 × 109 |
| Potassium chloride | 10 | 1.4 | 3.0 × 109 |
| Sodium phosphate | 10 | 1.4 | * |
Experimentally determined rates in dilute aqueous solution at RT (Buxton et al., 1988 ▶). *Reaction too slow to be detected.